Packaged Facts data indicates weight loss dieters who report being 30 or more pounds overweight are more likely to use non-prescription diet products and commercial weight loss systems.
Accoring to the CRN survey, the multivitamin has the highest percentage of usage among supplement users, both male (79%) and female (77%).
The drug uses SoluMatrix’s Fine Particle Technology to meet FDA guidelines that an NSAID contain the smallest possible dose over the shortest amount of time to prevent adverse drug events.
StopsBleeding is a sterile modified amylopectin, organic powder which effectively stops bleeding.
Aurobindo Pharma announced Thursday that it had received approval for its generic Namenda (memantine HCL) tablets.
Merrimack Pharmaceuticals’ new pancreatic cancer drug was approved by the FDA Thursday.
Camber has unveiled its generic of Merck’s Singulair (montelukast sodium) chewable tablets for chronic asthma treatment.
Guanfacine extended-release tablets are indicated to treat attention deficit/hyperactivity disorder in children and adolescents ages 6 to 17.
The Food and Drug Administration Thursday announced that it had approved Relypsa’s Veltassa (patiromer) for oral suspension.
Delivered to physicians through DrFirst’s myBenefitCheck, Humana’s IntelligentRx service provides doctors with patient-specific prescription price information at the time the prescription is being written.